Cargando…

Rewiring Tumor Cell State in Cancer Therapy: Comment on ‘9-cis-UAB30, a Novel Rexinoid Agonist, Decreases Tumorigenicity and Cancer Cell Stemness of Human Neuroblastoma Patient-Derived Xenografts’ by ‘Elizabeth Beierle et al.’

Detalles Bibliográficos
Autor principal: Chakraborty, Abhishek A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718159/
https://www.ncbi.nlm.nih.gov/pubmed/33276293
http://dx.doi.org/10.1016/j.tranon.2020.100967
_version_ 1783619454723162112
author Chakraborty, Abhishek A.
author_facet Chakraborty, Abhishek A.
author_sort Chakraborty, Abhishek A.
collection PubMed
description
format Online
Article
Text
id pubmed-7718159
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Neoplasia Press
record_format MEDLINE/PubMed
spelling pubmed-77181592020-12-15 Rewiring Tumor Cell State in Cancer Therapy: Comment on ‘9-cis-UAB30, a Novel Rexinoid Agonist, Decreases Tumorigenicity and Cancer Cell Stemness of Human Neuroblastoma Patient-Derived Xenografts’ by ‘Elizabeth Beierle et al.’ Chakraborty, Abhishek A. Transl Oncol Preview Neoplasia Press 2020-12-01 /pmc/articles/PMC7718159/ /pubmed/33276293 http://dx.doi.org/10.1016/j.tranon.2020.100967 Text en © 2020 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Preview
Chakraborty, Abhishek A.
Rewiring Tumor Cell State in Cancer Therapy: Comment on ‘9-cis-UAB30, a Novel Rexinoid Agonist, Decreases Tumorigenicity and Cancer Cell Stemness of Human Neuroblastoma Patient-Derived Xenografts’ by ‘Elizabeth Beierle et al.’
title Rewiring Tumor Cell State in Cancer Therapy: Comment on ‘9-cis-UAB30, a Novel Rexinoid Agonist, Decreases Tumorigenicity and Cancer Cell Stemness of Human Neuroblastoma Patient-Derived Xenografts’ by ‘Elizabeth Beierle et al.’
title_full Rewiring Tumor Cell State in Cancer Therapy: Comment on ‘9-cis-UAB30, a Novel Rexinoid Agonist, Decreases Tumorigenicity and Cancer Cell Stemness of Human Neuroblastoma Patient-Derived Xenografts’ by ‘Elizabeth Beierle et al.’
title_fullStr Rewiring Tumor Cell State in Cancer Therapy: Comment on ‘9-cis-UAB30, a Novel Rexinoid Agonist, Decreases Tumorigenicity and Cancer Cell Stemness of Human Neuroblastoma Patient-Derived Xenografts’ by ‘Elizabeth Beierle et al.’
title_full_unstemmed Rewiring Tumor Cell State in Cancer Therapy: Comment on ‘9-cis-UAB30, a Novel Rexinoid Agonist, Decreases Tumorigenicity and Cancer Cell Stemness of Human Neuroblastoma Patient-Derived Xenografts’ by ‘Elizabeth Beierle et al.’
title_short Rewiring Tumor Cell State in Cancer Therapy: Comment on ‘9-cis-UAB30, a Novel Rexinoid Agonist, Decreases Tumorigenicity and Cancer Cell Stemness of Human Neuroblastoma Patient-Derived Xenografts’ by ‘Elizabeth Beierle et al.’
title_sort rewiring tumor cell state in cancer therapy: comment on ‘9-cis-uab30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts’ by ‘elizabeth beierle et al.’
topic Preview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718159/
https://www.ncbi.nlm.nih.gov/pubmed/33276293
http://dx.doi.org/10.1016/j.tranon.2020.100967
work_keys_str_mv AT chakrabortyabhisheka rewiringtumorcellstateincancertherapycommenton9cisuab30anovelrexinoidagonistdecreasestumorigenicityandcancercellstemnessofhumanneuroblastomapatientderivedxenograftsbyelizabethbeierleetal